Exciting Data on Developing Drugs for Myelofibrosis

Published on

Topics include: Treatments

Over the past year, there has been continued progress in improving treatments for myelofibrosis. In this video, Dr. Claire Harrison, noted expert in the treatment of myeloproliferative conditions, shares updated news about  three-year data from the Comfort II study.  She shares information that is coming in showing an ongoing positive response to the treatment regimen with ruxolitinib without seeing many new or intolerable side effects. Watch now.

View more programs featuring

Join Our Community Register for Events Read Our Latest Blog

Page last updated on January 26, 2016